10 million SEK to national study of COVID-19
The Swedish Research Council is providing 10 million SEK to fund the ImmCoVA clinical study. The study is expected to run for three years, and focuses on immune blockers to counteract excess reaction of the immune system to the infection caused by COVID-19.
In June, we reported that the Swedish Research Council was to fund Sweden’s participation in the Solidarity trial, a major clinical WHO study, where a number of antiviral medicines are tested on patients being treated for COVID-19. However, due to the high level of mortality seen in patients receiving some of these medicines, the Swedish network for the WHO study decided that Sweden would not participate in the study.
Instead, the Swedish Research Council is now providing the same network of infection clinics in Sweden with funding of 10 million SEK to conduct another national study into COVID-19. The study is called ImmCoVA, and is expected to run for three years, starting in October. The study focuses on immune blockers to counteract excess reaction of the immune system to infection, known as ‘cytokine storm’. The study will investigate whether treatment with two specific immunosuppressing substances can result in improvement, and at best in patients recovering more quickly than with standard treatments.
The Karolinska University Hospital is leading the study, and patients will be recruited from five university hospitals.
MORE WITHIN THE SAME SUBJECT AREA
Published 29 November 2021
The Swedish Research Council arrange a seminar on the upcoming evaluation of the quality of clinical research conducted in the regions that are subject to the ALF agreement. The purpose of the seminar is to inform about the upcoming evaluation. The r...
Published 19 November 2021
We have now decided on the dates for 40 or our calls next year. Many of calls are recurrent, but some will be issued for the first time. The new calls are shown in the list below. More calls will be added.
Published 15 November 2021
The Swedish Research Council is allocating 50 million SEK to 14 research projects into post-COVID syndrome. The research shall contribute to developing knowledge within health and medical care, and improving diagnosis and therapy alternatives for pat...